Leishmaniasis, Visceral

"Leishmaniasis, Visceral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Descriptor ID	D007898
MeSH Number(s)	C03.752.300.500.510
Concept/Terms	Leishmaniasis, Visceral Leishmaniasis, Visceral Visceral Leishmaniasis Kala-Azar Kala Azar Black Fever Fever, Black

Below are MeSH descriptors whose meaning is more general than "Leishmaniasis, Visceral".

Diseases [C]
Parasitic Diseases [C03]
Protozoan Infections [C03.752]
Euglenozoa Infections [C03.752.300]
Leishmaniasis [C03.752.300.500]
Leishmaniasis, Visceral [C03.752.300.500.510]

Below are MeSH descriptors whose meaning is related to "Leishmaniasis, Visceral".

Below are MeSH descriptors whose meaning is more specific than "Leishmaniasis, Visceral".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Leishmaniasis, Visceral" by people in this website by year, and whether "Leishmaniasis, Visceral" was a major or minor topic of these publications.

Bar chart showing 13 publications over 13 distinct years, with a maximum of 1 publications in 1995 and 2007 and 2008 and 2011 and 2012 and 2014 and 2016 and 2018 and 2019 and 2021 and 2022 and 2023 and 2025

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
2007	1	0	1
2008	1	0	1
2011	1	0	1
2012	1	0	1
2014	0	1	1
2016	0	1	1
2018	1	0	1
2019	1	0	1
2021	1	0	1
2022	1	0	1
2023	1	0	1
2025	1	0	1

Below are the most recent publications written about "Leishmaniasis, Visceral" by people in Profiles.

de Oliveira B, Goes WM, Nascimento FC, Carnielli JBT, Ferreira ER, de Carvalho AF, Dos Reis PVM, Pereira M, Ricotta TQN, Dos Santos LM, de Souza RP, Cargnelutti DE, Mottram JC, Teixeira SR, Fernandes AP, Gazzinelli RT. Characterization of a novel Leishmania antigen containing a repetitive domain and its potential use as a prophylactic and therapeutic vaccine. mSphere. 2025 May 27; 10(5):e0009725.

View in: PubMed
Rogerio LA, Takahashi TY, Cardoso L, Takamiya NT, de Melo EV, de Jesus AR, de Oliveira FA, Forrester S, Jeffares DC, da Silva JS, Ribeiro JM, Almeida RP, Maruyama SR. Co-infection of Leishmania infantum and a Crithidia-related species in a case of refractory relapsed visceral leishmaniasis with non-ulcerated cutaneous manifestation in Brazil. Int J Infect Dis. 2023 Aug; 133:85-88.

View in: PubMed
Grace CA, Sousa Carvalho KS, Sousa Lima MI, Costa Silva V, Reis-Cunha JL, Brune MJ, Forrester S, Pedrozo E Silva de Azevedo CM, Costa DL, Speed D, Mottram JC, Jeffares DC, Costa CHN. Parasite Genotype Is a Major Predictor of Mortality from Visceral Leishmaniasis. mBio. 2022 12 20; 13(6):e0206822.

View in: PubMed
Figueiredo MM, Dos Santos ARR, Godoi LC, de Castro NS, de Andrade BC, Sergio SAR, Jer?nimo SMB, de Oliveira EJ, Valencia-Portillo RT, Bezerra LM, Goto H, Sanchez MCA, Junqueira C, Teixeira SMR, da Fonseca FG, Gazzinelli RT, Fernandes AP. Improved Performance of ELISA and Immunochromatographic Tests Using a New Chimeric A2-Based Protein for Human Visceral Leishmaniasis Diagnosis. J Immunol Res. 2021; 2021:5568077.

View in: PubMed
Santos ARRD, Serufo ?V, Figueiredo MM, Godoi LC, Vit?rio JG, Marcelino AP, Avelar DM, Rodrigues FTG, Machado-Coelho GLL, Medeiros FAC, Jer?nimo SMB, Oliveira EJ, Nascimento FC, Teixeira SMR, Gazzinelli RT, Nagem RAP, Fernandes AP. Evaluation of three recombinant proteins for the development of ELISA and immunochromatographic tests for visceral leishmaniasis serodiagnosis. Mem Inst Oswaldo Cruz. 2019 Feb 04; 114:e180405.

View in: PubMed
Martins TAF, Barbosa VS, Almeida GG, Antonelli LRDV, Tafuri WL, Mosser DM, Gon?alves R. Monocyte subpopulations as important biomarkers of resistence and susceptibility during experimental infection with Leishmania (Leishmania) major. Biomed Pharmacother. 2018 Nov; 107:1530-1539.

View in: PubMed
Barbosa LA, Fiuza PP, Borges LJ, Rolim FA, Andrade MB, Luz NF, Quintela-Carvalho G, Lima JB, Almeida RP, Chan FK, Bozza MT, Borges VM, Prates DB. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives Leishmania infantum Killing in Neutrophils. Front Immunol. 2018; 9:1818.

View in: PubMed
Farias Luz N, Balaji S, Okuda K, Barreto AS, Bertin J, Gough PJ, Gazzinelli R, Almeida RP, Bozza MT, Borges VM, Chan FK. RIPK1 and PGAM5 Control Leishmania Replication through Distinct Mechanisms. J Immunol. 2016 06 15; 196(12):5056-63.

View in: PubMed
Pigott DM, Golding N, Messina JP, Battle KE, Duda KA, Balard Y, Bastien P, Pratlong F, Brownstein JS, Freifeld CC, Mekaru SR, Madoff LC, George DB, Myers MF, Hay SI. Global database of leishmaniasis occurrence locations, 1960-2012. Sci Data. 2014; 1:140036.

View in: PubMed
Abeijon C, Campos-Neto A. Potential non-invasive urine-based antigen (protein) detection assay to diagnose active visceral leishmaniasis. PLoS Negl Trop Dis. 2013; 7(5):e2161.

View in: PubMed

People

Explore

Similar Concepts

Top Journals